We also demonstrated that quantifying and sequencing SEC23B mRNA from peripheral lymphocytes (and not only from erythroid cultures) might facilitate the genetic diagnosis of CDAII. Here, SEC23B is linked to congenital dyserythropoietic anemia type 2.